An ambitious plan to sequence genomes for 1.85 million eukaryotic species on our planet is underway. It's a massive ...

Korro’s lead program for alpha-1 antitrypsin deficiency wasn’t as potent as anticipated, leading the company to change course ...

Director Chloé Zhao discusses rhythm, pacing and rewriting in the edit while co-editing 'Hamnet' with editor Affonso Gonçalves.

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

Clustered regularly interspaced palindromic repeats(CRISPR) gene editing, known for its precision, is revolutionizing tumor research and treatment. This article covers the evolution of the CRISPR ...